Assignee
CURNA INC
US·69 granted patents·9 pending applications·73 citations·filing 2013–2021
Top patents by PatentIndex Score
78 records- 0192US9410155B2Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGFCURNA INC·Filed 2014·Granted Aug 9, 2016·14 cites·12 claims
- 0287US9382538B2Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisense transcript to CSF3CURNA INC·Filed 2015·Granted Jul 5, 2016·5 cites·16 claims
- 0385US11697814B2Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the geneCURNA INC·Filed 2019·Granted Jul 11, 2023·1 cites·14 claims
- 0485US10696966B2Treatment of sex hormone binding globulin (SHBG) related diseases by inhibition of natural antisense transcript to SHBGCURNA INC·Filed 2015·Granted Jun 30, 2020·2 cites·20 claims
- 0584US10934546B2Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)CURNA INC·Filed 2020·Granted Mar 2, 2021·1 cites·18 claims
- 0684US9902959B2Treatment of Frataxin (FXN) related diseases by inhibition of natural antisense transcript to FXNCURNA INC·Filed 2017·Granted Feb 27, 2018·3 cites·14 claims
- 0783US10253320B2Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1CURNA INC·Filed 2018·Granted Apr 9, 2019·2 cites·6 claims
- 0882US10487327B2Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factorCURNA INC·Filed 2018·Granted Nov 26, 2019·2 cites·12 claims
- 0981US10793857B2Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNACURNA INC·Filed 2017·Granted Oct 6, 2020·1 cites·10 claims
- 1081US10604755B2Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism geneCURNA INC·Filed 2015·Granted Mar 31, 2020·2 cites·15 claims
- 1181US10337011B2Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21CURNA INC·Filed 2017·Granted Jul 2, 2019·2 cites·10 claims
- 1281US10100315B2Treatment of PAR4 related diseases by inhibition of natural antisense transcript to PAR4CURNA INC·Filed 2017·Granted Oct 16, 2018·2 cites·8 claims
- 1381US9920369B2Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisene transcript to CSF3CURNA INC·Filed 2016·Granted Mar 20, 2018·2 cites·14 claims
- 1481US9920322B2Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGFCURNA INC·Filed 2016·Granted Mar 20, 2018·2 cites·15 claims
- 1581US9902995B2Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related disease by inhibition of natural antisense transcript to PYCR1CURNA INC·Filed 2016·Granted Feb 27, 2018·2 cites·14 claims
- 1680US10563202B2Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)CURNA INC·Filed 2015·Granted Feb 18, 2020·2 cites·13 claims
- 1780US9611477B2Treatment of tristetraproline (TTP) related diseases by inhibition of natural antisense transcript to TTPCURNA INC·Filed 2015·Granted Apr 4, 2017·2 cites·16 claims
- 1880US9267136B2Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental geneCURNA INC·Filed 2014·Granted Feb 23, 2016·3 cites·34 claims
- 1979US10221413B2Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2CURNA INC·Filed 2015·Granted Mar 5, 2019·2 cites·15 claims
- 2079US9914923B2Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factorCURNA INC·Filed 2015·Granted Mar 13, 2018·2 cites·10 claims
- 2179US9528110B2Treatment of ‘IQ motif containing gtpase activating protein’ (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAPCURNA INC·Filed 2015·Granted Dec 27, 2016·2 cites·16 claims
- 2278US10876117B2Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome geneCURNA INC·Filed 2019·Granted Dec 29, 2020·0 cites·14 claims
- 2378US10113166B2Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activityCURNA INC·Filed 2014·Granted Oct 30, 2018·2 cites·15 claims
- 2478US2022195439A1Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnfCURNA INC·Filed 2021·Application pending·0 cites
- 2577US10337013B2Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1CURNA INC·Filed 2017·Granted Jul 2, 2019·1 cites·9 claims
- 2677US10280421B2Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8CURNA INC·Filed 2017·Granted May 7, 2019·1 cites·11 claims
- 2777US10053691B2Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOGCURNA INC·Filed 2017·Granted Aug 21, 2018·1 cites·14 claims
- 2877US9714423B2Treatment of Paraoxonase 1 (PON1) related diseases by inhibition of natural antisense transcript to PON1CURNA INC·Filed 2014·Granted Jul 25, 2017·2 cites·15 claims
- 2976US10370657B2Treatment of Collagen gene related diseases by inhibition of natural antisense transcript to a collagen geneCURNA INC·Filed 2016·Granted Aug 6, 2019·1 cites·14 claims
- 3074US10358646B2Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the geneCURNA INC·Filed 2014·Granted Jul 23, 2019·1 cites·10 claims
- 3174US9902958B2Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLGCURNA INC·Filed 2016·Granted Feb 27, 2018·1 cites·11 claims
- 3273US11339394B2Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen geneCURNA INC·Filed 2019·Granted May 24, 2022·0 cites·14 claims
- 3372US9879264B2Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1CURNA INC·Filed 2015·Granted Jan 30, 2018·1 cites·13 claims
- 3472US9725756B2Treatment of ‘C terminus of HSP7O-interacting protein’ (CHIP) related diseases by inhibition of natural antisense transcript to CHIPCURNA INC·Filed 2014·Granted Aug 8, 2017·1 cites·15 claims
- 3572US9725717B2Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to TFE3CURNA INC·Filed 2014·Granted Aug 8, 2017·1 cites·15 claims
- 3672US9663785B2Treatment of nuclear respiratory factor 1 (NRF1) related diseases by inhibition of natural antisense transcript to NRF1CURNA INC·Filed 2014·Granted May 30, 2017·1 cites·15 claims
- 3771US11390868B2Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activityCURNA INC·Filed 2018·Granted Jul 19, 2022·0 cites·12 claims
- 3871US10519448B2Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNFCURNA INC·Filed 2015·Granted Dec 31, 2019·1 cites·15 claims
- 3971US9677074B2Treatment of insulin receptor substrate 2 (IRS2) related diseases by inhibition of natural antisense transcript to IRS2 and transcription factor E3 (TFE3)CURNA INC·Filed 2015·Granted Jun 13, 2017·1 cites·12 claims
- 4071US2020291407A1Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnfCURNA INC·Filed 2020·Application pending·0 cites
- 4170US9732339B2Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63CURNA INC·Filed 2015·Granted Aug 15, 2017·1 cites·15 claims
- 4266US10450567B2Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome geneCURNA INC·Filed 2018·Granted Oct 22, 2019·0 cites·11 claims
- 4366US10036014B2Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome geneCURNA INC·Filed 2014·Granted Jul 31, 2018·0 cites·18 claims
- 4466US9624493B2Treatment of atonal homolog 1 (ATOH1) related diseases by inhibition of natural antisense transcript to ATOH1CURNA INC·Filed 2014·Granted Apr 18, 2017·0 cites·16 claims
- 4566US2019040394A1Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnfCURNA INC·Filed 2018·Application pending·0 cites
- 4665US10316317B2Treatment of adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an adiponectin (ADIPOQ)CURNA INC·Filed 2018·Granted Jun 11, 2019·0 cites·12 claims
- 4764US9834767B2Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8CURNA INC·Filed 2014·Granted Dec 5, 2017·0 cites·15 claims
- 4864US9765336B2Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPOCURNA INC·Filed 2014·Granted Sep 19, 2017·0 cites·13 claims
- 4964US9745582B2Treatment of RNASE H1 related diseases by inhibition of natural antisense transcript to RNASE H1CURNA INC·Filed 2014·Granted Aug 29, 2017·0 cites·14 claims
- 5063US9133456B2Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral geneCURNA INC·Filed 2014·Granted Sep 15, 2015·0 cites·17 claims
Showing the top 50 of 78 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CURNA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →